| Reforming Pharmaceutical Industry-Physician Financial Relationships: Lessons from the United States, France, and Japan. | |
| | |
MedLine Citation:
|
PMID: 22084852 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
This article compares the means that the United States, France, and Japan use to oversee pharmaceutical industry-physician financial relationships. These countries rely on professional and/or industry ethical codes, anti-kickback laws, and fair trade practice laws. They restrict kickbacks the most strictly, allow wide latitude on gifts, and generally permit drug firms to fund professional activities and associations. Consequently, to avoid legal liability, drug firms often replace kickbacks with gifts and grants. The paper concludes by proposing reforms that address problems that persist when firms replace kickbacks with gifts and grants based on the experience of the three countries. |
| | |
Authors:
|
Marc A Rodwin |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics Volume: 39 ISSN: 1748-720X ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-11-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9315583 Medline TA: J Law Med Ethics Country: - |
Other Details:
|
Languages: ENG Pagination: 662-670 Citation Subset: - |
Copyright Information:
|
© 2011 American Society of Law, Medicine & Ethics, Inc. |
Affiliation:
|
Edmond J. Safra Research Lab Fellow at Harvard University and Professor of Law at Suffolk University Law School, is the author of Conflicts of Interest and the Future of Medicine: The United States, France and Japan (Oxford, 2011) and Medicine, Money and Morals: Physicians' Conflicts of Interest (1993). |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: An Ethics Expertise for Clinical Ethics Consultation.
Next Document: Me and My Body: The Relevance of the Distinction for the Difference between Withdrawing Life Support...